T/CHATA 021-2022 Guidelines for treating patients with varying degrees of liver damage caused by anti-tuberculosis drugs

Scope

This document provides the clinical grading of liver damage caused by anti-tuberculosis drugs, commonly used liver-protective drugs, grading treatment principles and schemes of liver-protective drugs for liver damage caused by anti-tuberculosis drugs, principles of adjusting anti-tuberculosis drug treatment, and guidelines for risk assessment and monitoring of liver damage.
This document is applicable to the management of drug-induced liver damage caused by anti-tuberculosis treatment or preventive treatment in tuberculosis patients or latent tuberculosis infection patients diagnosed by all levels and types of medical and health institutions.

Development Information

Related Standards